Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Al V Taira

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
International Journal of Radiation Oncology, Biology, Physics|December 27, 2011
20 Gy versus 44 Gy of supplemental external beam radiotherapy with palladium-103 for patients with greater risk disease: results of a prospective randomized trialGregory S Merrick, Kent E Wallner, Wayne M Butler, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Long-term outcome for clinically localized prostate cancer treated with permanent interstitial brachytherapyAl V Taira, Gregory S Merrick, Wayne M Butler, et al.
International Journal of Radiation Oncology, Biology, Physics|June 14, 2011
Distant metastases following permanent interstitial brachytherapy for patients with clinically localized prostate cancerAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
Journal of Contemporary Brachytherapy|January 30, 2014
Time to failure after definitive therapy for prostate cancer: implications for importance of aggressive local treatmentAl V Taira, Gregory S Merrick, Wayne M Butler, et al.
Brachytherapy|February 12, 2013
Long-term outcomes of prostate cancer patients with Gleason pattern 5 treated with combined brachytherapy and external beam radiotherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
International Journal of Radiation Oncology, Biology, Physics|April 12, 2011
Serum testosterone kinetics after brachytherapy for clinically localized prostate cancerAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
American Journal of Clinical Oncology|February 7, 2012
Transperineal template-guided mapping biopsy as a staging procedure to select patients best suited for active surveillanceAl V Taira, Gregory S Merrick, Abbey Bennett, et al.
Brachytherapy|March 13, 2012
Prognostic importance of tobacco use in men receiving definitive prostate brachytherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2009
Pretreatment serum testosterone and androgen deprivation: effect on disease recurrence and overall survival in prostate cancer patients treated with brachytherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2009
Erectile function durability following permanent prostate brachytherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
International Journal of Radiation Oncology, Biology, Physics|December 27, 2011
20 Gy versus 44 Gy of supplemental external beam radiotherapy with palladium-103 for patients with greater risk disease: results of a prospective randomized trialGregory S Merrick, Kent E Wallner, Wayne M Butler, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Long-term outcome for clinically localized prostate cancer treated with permanent interstitial brachytherapyAl V Taira, Gregory S Merrick, Wayne M Butler, et al.
International Journal of Radiation Oncology, Biology, Physics|June 14, 2011
Distant metastases following permanent interstitial brachytherapy for patients with clinically localized prostate cancerAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
Journal of Contemporary Brachytherapy|January 30, 2014
Time to failure after definitive therapy for prostate cancer: implications for importance of aggressive local treatmentAl V Taira, Gregory S Merrick, Wayne M Butler, et al.
Brachytherapy|February 12, 2013
Long-term outcomes of prostate cancer patients with Gleason pattern 5 treated with combined brachytherapy and external beam radiotherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
International Journal of Radiation Oncology, Biology, Physics|April 12, 2011
Serum testosterone kinetics after brachytherapy for clinically localized prostate cancerAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
American Journal of Clinical Oncology|February 7, 2012
Transperineal template-guided mapping biopsy as a staging procedure to select patients best suited for active surveillanceAl V Taira, Gregory S Merrick, Abbey Bennett, et al.
Brachytherapy|March 13, 2012
Prognostic importance of tobacco use in men receiving definitive prostate brachytherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2009
Pretreatment serum testosterone and androgen deprivation: effect on disease recurrence and overall survival in prostate cancer patients treated with brachytherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2009
Erectile function durability following permanent prostate brachytherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
Pageof 3